Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.
Winter 2021/2022

Stepping Up to Take on Pandemic Ripple Effects

A message from the Chief Executive Officer
Winter 2021/2022

Ask a Clinician: What Is the Difference Between Physical and Occupational Therapies?

Healthe's clinicians tackle common workers' comp questions
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Recalls and Alerts Impacting Workers’ Comp

The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.
Aug 2024

Weighing the Options: Keeping Track of New Obesity Drugs

Comorbid obesity can complicate recovery, and new drugs create new pharmacy considerations.
Aug 2024

Worker Heat Protections Continue to Make Waves

The U.S. Department of Labor proposed new rules, while other states introduce legislation.
Aug 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020

FDA Diagnostic Testing Updates

The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Apr 2020
1 … 13 14 15 16 17 … 26

Whitepapers

lockmap-markermagnifiercrossmenucross-circle